Resultado da Busca
Há 16 horas · Oppenheimer is changing the firm’s estimates for Microsoft’s Azure revenue and CAPX by lowering Azure revenue, and putting CapEx spending around $2B below the Street the next few years after ...
Há 23 minutos · Restaurant Delivery Apps Have 'Large Opportunity' to Capture New Users, Oppenheimer Survey Shows 12:09pm: MT Oppenheimer Adjusts Price Target on Uber Technologies to $95 From $90, Maintains Outperform Rating 06:46am: MT
Há 16 horas · The survey, conducted by Oppenheimer, shows that 64% of restaurant delivery users and 70% of grocery delivery users are spending more than they did six months ago, driven by product improvements such as faster delivery times and fewer order mistakes. This trend has led to increased confidence, prompting a 2% boost in Uber Delivery and DoorDash ...
Há 16 horas · REDWOOD CITY, Calif., Sept. 27, 2024 (GLOBE NEWSWIRE) -- AmMax Bio, Inc., a private clinical-stage biopharmaceutical company developing innovati...
Há 16 horas · El viernes, Oppenheimer ha aumentado el precio objetivo para las acciones de Kymera Therapeutics (NASDAQ:KYMR) a 56 dólares, desde los 52 dólares anteriores, mientras que mantiene una calificación de Outperform en la acción. El ajuste se produce tras una reciente ronda de financiación y refleja ...
Há 16 horas · Oppenheimer On Costco Wholesale. Analyst Rupesh Parikh reaffirmed an Outperform rating and price target of $955. Costco's adjusted earnings grew by around 6% to $5.15 per share, ...
Há 16 horas · Laatste nieuws over Kymera Therapeutics, Inc. KYMERA THERAPEUTICS, INC. : Oppenheimer herhaalt koopadvies. 1 Uur geleden. ZM. Kymera Therapeutics zegt dat zijn potentiële IND KT-621 ontstekingen vermindert in preklinische modellen. 25/09. MT. Kymera Therapeutics, Inc. Presents at Morgan Stanley 22nd Annual Global Healthcare Conference, Sep-05 ...
